In the news

News headlines are articles that reference ResMed's company, people, or business practices.

Advanced Search
  • December 8, 2017
    Berg Insight

    Berg Insight estimates that the installed base of connected sleep therapy devices reached 3.4 million units at the end of 2016, which can be compared with 2.0 million units in 2015. The rapid increase is to a large extent due to ResMed’s push in the market. ResMed has established itself as the clear market leader in remote monitoring of sleep therapy patients with an estimated 2.0 million connected patients at the end of 2016.

  • December 6, 2017
    MD+DI

    ResMed has been named a 2017 “Medtech Company of the Year” finalist by MD+DI, a leading news resource in the medical device and diagnostic industry.

  • November 7, 2017
    mobiHealthNews

    Monitoring sleep disorders while traveling just became easier this week after the San Diego based company, ResMed announced that the AirMini, a miniature CPAP device, will now to be able to connect to the AirView, a remote patient monitoring platform.

  • October 2, 2017
    Seeking Alpha

    ResMed I thought was a great BUY in the $60 per share range, and a good buy at $73. It still is for investors after topping an all-time high price.

  • September 14, 2017
    San Diego Business Journal

    San Diego-based companies like ResMed and NuVasive Inc. argue the tax stifles research and development, job creation and innovation.

  • September 12, 2017
    HME News

    The use of CPAP telemonitoring with automated feedback messaging improved 90-day adherence in patients with obstructive sleep apnea, according to a ResMed-supported study published in American Journal of Respiratory and Clinical Care Medicine.

  • September 5, 2017
    Parks Associates

    Kari Hall, VP, Global Software Services at ResMed, recently spoke with Parks Associates about the future of healthcare. Kari was also a speaker at Parks Associates’ annual Connected Health Summit in San Diego, where she and speakers from 2bPrecise, Kaiser, Qualcomm, and UPMC Insurance Services spoke about the business opportunities available through precision medicine.

  • August 27, 2017
    RT Magazine

    “Because ALS is a progressive disease, many patients receive NIV via a life support device, like ResMed’s Astral ventilator, which can be utilized throughout the course of the disease," said Denise Hartsell, RRT, RPSGT, Senior Product Manager, Ventilation at ResMed.

  • August 8, 2017
    Frequent Business Traveler

    A close family member was recently diagnosed with sleep apnea and we’ve found that traveling with his home therapy equipment was an onerous imposition. With that in mind I recently went hunting for portable equipment to use instead. My conclusion? There was just one machine worth considering: the AirMini from ResMed.

  • August 7, 2017
    UC San Diego

    This year, six new trustees, including ResMed CEO Mick Farrell, and two returning trustees will join the 2017-18 Foundation Board.

  • Sleep Review
    August 4, 2017
    Sleep Review

    Proponents say oral appliances can be made faster and more accurately when intraoral scanning, computer-aided design, and computer-aided manufacturing (CAD/CAM) are utilized.

  • July 19, 2017
    S&P Dow Jones Indices

    Effective prior to the open of trading on Wednesday, July 26: S&P MidCap 400 constituents ResMed Inc. (NYSE:RMD), Packaging Corporation of America (NYSE:PKG), A.O. Smith Corp. (NYSE:AOS) and Duke Realty Corp.
    (NYSE:DRE) will replace Mallinckrodt plc (NYSE:MNK), Murphy Oil Corp (NYSE:MUR), Bed Bath & Beyond Inc. (NASD:BBBY) and Transocean Ltd (NYSE:RIG) respectively, in the S&P 500.

  • July 5, 2017
    HME News

    Brightree announced today that it has bought AllCall Connect, a Joliet, Ill.-based provider of live-calling solutions for CPAP patient resupply, its second acquisition in as many months.

  • June 28, 2017
    ABC News: Good Morning America

    ABC News' Paula Faris shares the story of how she found out her husband's snoring was caused by sleep apnea and looks at some possible snoring solutions.

  • June 13, 2017
    Sleep Review

    A large study finds that ASV yields better compliance among obstructive sleep apnea patients who develop treatment-emergent central sleep apnea than does CPAP. Researchers discuss why and what it means in clinical practice.

  • June 13, 2017
    Medical Devices

    This presentation is a must for anyone who wants to understand how dramatically the smart use of big data can impact the entire healthcare system. With ResMed’s investments in digitization, they are lowering costs for sleep apnea and COPD therapy and increasing patient adherence.

  • June 9, 2017
    Sleep Review

    Boosted by launches [like ResMed's AirMini], the market for small positive airway pressure devices has never been bigger.

  • June 7, 2017
    mHealth Intelligence

    Healthcare providers are using mobile health technology to transform clunky CPAP devices into high-tech mHealth platforms, giving doctors better insight into sleep and breathing problems.

  • June 5, 2017
    Bloomberg (starts at 27:40)

    ResMed Chief Medical Officer Carlos M. Nunez, M.D., discussed sleep apnea, why ResMed connected 3 million sleep devices to the cloud, and his thoughts on sleep trackers, with Bloomberg Baystate Business Hour host Anne Mostue.

  • May 25, 2017
    Journal of Translational Medicine

    The recognition and treatment of sleep-disordered breathing is vital for the continued health and wellbeing of individual patients with SDB.

  • May 22, 2017
    PCHAlliance

    The Personal Connected Health Alliance (PCHAlliance) today announced the addition of twelve new member companies during the first quarter of 2017, including five at the Global level -- AT&T, Eli Lilly and Company, IPSOS Healthcare, ResMed and Samsung. As a Global Member, each had the opportunity to nominate an executive to the PCHAlliance Board of Managers and all have been accepted.

  • May 21, 2017
    MedPage Today

    Patients with persistent hypercapnia following an acute exacerbation of chronic obstructive pulmonary disease (COPD) had a longer time to death or rehospitalization if non-interventional ventilation was added to their home oxygen therapy, researchers found.

  • May 16, 2017
    Sleep Review

    ResMed Inc announced that people with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant on therapy after they switch from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to the largest-ever analysis of patients with treatment-emergent CSA.

  • May 8, 2017
    Becker's Hospital Review

    Amy Cook, Director of Healthcare Informatics at ResMed, was named to Becker's list of 110 Women in Medtech to Know in 2017. Joining ResMed in 2012, she was integral in developing and rolling out the company's suite of connected health IT services and platforms.

  • Medgadget logo
    May 3, 2017
    Medgadget

    The S+ platform is the newest technology disrupting the $60B consumer sleep industry. Developed by SleepScore Labs, a joint venture between ResMed, a 25-year leader in prescription sleep medical devices, Dr. Mehmet Oz, and Pegasus Capital Advisors, the S+ is a clinical grade, non-prescription, non-contact sleep monitoring device coupled with a mobile app.

Show 5102550100 per page
Media contacts - Bottom Blue - All Interior Pages

Media contacts

Global

Alison Graves
(858) 836-6789

Americas

Jayme Rubenstein
(858) 836-6798

EMEA, Japan

Juliette Lambert
(33) 646-621-241

Asia-Pacific

Paul McKeon
(61) 2-8884-2596

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages